Status:
COMPLETED
Values and Options in Cancer Care 2 (VOICE 2) A Randomized Pilot Study
Lead Sponsor:
Rutgers, The State University of New Jersey
Conditions:
Communication, Multidisciplinary
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Primary Objective: Aim 1: To evaluate the acceptability and feasibility of recruitment strategies for subjects for VOICE 2 intervention. Secondary Objective: Aim 2: To test the preliminary efficacy...
Detailed Description
The purpose of the research is to test whether the randomized recruitment of oncologist and their participants-caregivers dyads is feasible to improve communication and illness understanding in partic...
Eligibility Criteria
Inclusion
- Participant of an oncologist participating in this study
- Received a diagnosis of hematologic cancer with disease progression following second-line treatment, OR a diagnosis of stage IV gastrointestinal, genitourinary, gynecologic, skin/soft tissue or thoracic/head and neck cancer
- Fluent in English or Spanish and prefer speaking English or Spanish when talking about health care
- 21 years or older;
- Have a primary informal caregiver (as defined by an unpaid individual who provides you with emotional, physical, and/or practical support) who is willing and able to participate in the study
- Able to communicate over the phone with the study team staff
- Willing to be audio-recorded for study-related communication
Exclusion
- Test result on mental status do not meet the requirement for this study
- Receiving hospice care now
Key Trial Info
Start Date :
May 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT05352451
Start Date
May 9 2022
End Date
December 31 2024
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers Cancer Institute of New Jersey-University Hospital
New Brunswick, New Jersey, United States, 08903